x

Clinical Trials Archives – #BCSM

Active Surveillance for DCIS – the COMET Trial

9 April 2017 On Monday April 10th we will discuss the COMET trial, which is sponsored by the Alliance cooperative group. The principal investigator is Dr. Shelley Hwang, a surgical oncologist at Duke University. This study will evaluate active surveillance for low risk DCIS. The primary objective is to evaluate the rate of ipsilateral (same […]

Read more ›
The Metastatic Breast Cancer Project – An Update

Guest Post by Corrie Painter, Ph.D The Metastatic Breast Cancer Project is a nationwide patient-driven research project launched at the Broad Institute of MIT and Harvard & Dana-Farber Cancer Institute in October of 2015. Along with our advocacy partners (the Metastatic Breast Cancer Network, the Metastatic Breast Cancer Alliance, Living Beyond Breast Cancer, Young Survivor Coalition, […]

Read more ›
Highlights from #BCS15

By Deanna J. Attai MD and Julie R. Gralow MD The Breast Cancer Symposium is a multi-disciplinary breast cancer conference, co-sponsored by the American Society of Clinical Oncology, The American Society of Breast Surgeons, the Society of Surgical Oncology, and The American Society of Radiation Oncology. It is a unique meeting as representatives from surgery, […]

Read more ›
Genetic Testing for Breast Cancer Risk

On 8/10/15 we will discuss genetic testing for breast cancer risk with Drs. Mark Robson and Steven Katz. This Fact Sheet from the National Cancer Institute contains information about BRCA 1 and 2 mutations. This post by Dr. Robson discusses next generation genetic testing including important considerations. Dr. Steven Katz recently co-authored Treatment Decision Making and […]

Read more ›
All Hands On Deck – The Metastatic Breast Cancer Project

Guest Post by Corrie Painter, Ph.D We are at a point in history where the promise of transformative discovery is so real, that scientists are driven like never before. The tools and methods that we are developing have greatly increased our ability to answer questions that were once considered so challenging that they were never […]

Read more ›